MNZO
Manzo Pharmaceuticals, Inc. is a specialized drug company that focuses on the discovery, creation, and evaluation of both proprietary and generic medical treatments and therapies. The company is actively developing Lacto-Freedom, a patented probiotic designed to help individuals with lactose intolerance digest dairy-containing foods more easily. Additionally, it is crafting a natural solution for infant colic. Headquartered in Milford, Pennsylvania, the organization was formerly known as Fortune Oil & Gas, Inc. before adopting its current name, Manzo Pharmaceuticals, Inc., in September 2014.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2005 Q3 | -0.20 | $0 | — |
| 2004 Q4 | -0.30 | $0 | -$608,340 |
| 2004 Q3 | -0.30 | $0 | — |